CSIMarket
 


Zimvie Inc   (ZIMV)
Other Ticker:  
 

Zimvie Inc 's Quick Ratio

ZIMV's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Zimvie Inc 's Cash & cash equivalent grew by 13.95 % in the III Quarter 2023 sequentially, while Current Liabilities decreased, this led to improvement in Zimvie Inc 's Quick Ratio to 0.44, Quick Ratio remained below Zimvie Inc average.

Within Medical Equipment & Supplies industry 202 other companies have achieved higher Quick Ratio than Zimvie Inc in third quarter 2023. While Quick Ratio total ranking in the third quarter 2023 has deteriorated compared to the prior quarter from 1635 to 3670.

Explain Quick Ratio?
How much Cash & cash equivalents ZIMV´s has?
What are ZIMV´s Current Liabilities?


ZIMV Quick Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
Y / Y Current Liabilities Change -30.62 % -13.58 % 6.46 % - -
Y / Y Cash & cash equivalent Change -41.99 % -36.49 % -33.85 % - -
Quick Ratio MRQ 0.44 0.35 0.34 0.53 0.53
ZIMV's Total Ranking # 3670 # 1635 # 2882 # 2597 #
Seq. Current Liabilities Change -9.76 % -3.45 % -9.64 % -11.87 % 12.41 %
Seq. Cash & cash equivalent Change 13.95 % -0.3 % -42.75 % -10.8 % 24.74 %



Quick Ratio third quarter 2023 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 203
Healthcare Sector # 1068
Overall Market # 3670


Quick Ratio Statistics
High Average Low
0.54 0.46 0.34
(Dec 31 2021)   (Mar 31 2023)




Financial Statements
Zimvie Inc 's Current Liabilities $ 171 Millions Visit ZIMV's Balance sheet
Zimvie Inc 's Cash & cash equivalent $ 75 Millions Visit ZIMV's Balance sheet
Source of ZIMV's Sales Visit ZIMV's Sales by Geography


Cumulative Zimvie Inc 's Quick Ratio

ZIMV's Quick Ratio for the trailling 12 Months

ZIMV Quick Ratio

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
Y / Y Current Liabilities TTM Growth -30.62 % -13.58 % 6.46 % - -
Y / Y Cash & cash equivalent TTM Growth -41.99 % -36.49 % -33.85 % - -
Quick Ratio TTM 0.42 0.45 0.47 0.52 0.51
Total Ranking TTM # 3499 # 405 # 2536 # 2351 #
Seq. Current Liabilities TTM Growth -9.76 % -3.45 % -9.64 % -11.87 % 12.41 %
Seq. Cash & cash equivalent TTM Growth 13.95 % -0.3 % -42.75 % -10.8 % 24.74 %


On the trailing twelve months basis In spite of the year on year decrease in ZIMV's Current Liabilities to $171.22 millions, cumulative Quick Ratio to 0.42 below the ZIMV average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 196 other companies have achieved higher Quick Ratio than Zimvie Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2023 from 405 to 3499.

Explain Quick Ratio?
How much Cash & cash equivalents ZIMV´s has?
What are ZIMV´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 197
Healthcare Sector # 1037
Within the Market # 3499


trailing twelve months Quick Ratio Statistics
High Average Low
0.52 0.45 0.4
(Jun 30 2022)   (Jun 30 2022)




Companies with similar Quick Ratio in the quarter ending Sep 30 2023, within Medical Equipment & Supplies Industry Quick RatioSep 30 2023 MRQ Cash & cash equivalentSep 30 2023 MRQ Current Liabilities
Sharecare Inc   1.16 $ 128.008  Millions$ 110.615  Millions
Envista Holdings Corporation  1.10 $ 824.200  Millions$ 746.800  Millions
Tenon Medical Inc   1.09 $ 3.371  Millions$ 3.085  Millions
Brainsway Ltd   1.08 $ 10.520  Millions$ 9.761  Millions
Plus Therapeutics Inc   1.06 $ 11.006  Millions$ 10.421  Millions
Prosomnus Inc   1.04 $ 12.022  Millions$ 11.578  Millions
Establishment Labs Holdings Inc   1.04 $ 52.190  Millions$ 50.302  Millions
Angiodynamics Inc   1.00 $ 57.586  Millions$ 57.452  Millions
Cerus Corporation  0.99 $ 79.006  Millions$ 80.122  Millions
Innovage Holding Corp   0.97 $ 135.231  Millions$ 138.813  Millions
Artivion Inc   0.97 $ 53.481  Millions$ 54.959  Millions
Vapotherm Inc   0.96 $ 14.418  Millions$ 14.947  Millions
Biolife Solutions Inc   0.96 $ 41.029  Millions$ 42.622  Millions
Baxter International Inc   0.93 $ 5,788.000  Millions$ 6,209.000  Millions
Embecta Corp   0.92 $ 326.500  Millions$ 353.500  Millions
Allurion Technologies Inc   0.92 $ 79.866  Millions$ 87.228  Millions
Envoy Medical Inc   0.90 $ 11.440  Millions$ 12.690  Millions
Vaso Corporation  0.89 $ 26.893  Millions$ 30.298  Millions
Nuo Therapeutics Inc   0.85 $ 0.583  Millions$ 0.685  Millions
Privia Health Group Inc   0.85 $ 330.391  Millions$ 390.967  Millions
Medtronic Plc  0.80 $ 7,734.000  Millions$ 9,659.000  Millions
Lucid Diagnostics Inc   0.80 $ 24.050  Millions$ 30.224  Millions
Ss Innovations International Inc   0.80 $ 6.596  Millions$ 8.296  Millions
Cadre Holdings Inc   0.77 $ 69.412  Millions$ 89.706  Millions
Iridex Corp  0.77 $ 7.981  Millions$ 10.348  Millions
Integra Lifesciences Holdings Corp  0.77 $ 273.732  Millions$ 355.712  Millions
National Vision Holdings Inc   0.71 $ 265.815  Millions$ 373.528  Millions
Cytosorbents Corporation  0.70 $ 8.359  Millions$ 11.972  Millions
Quoin Pharmaceuticals Ltd   0.69 $ 3.163  Millions$ 4.580  Millions
Avanos Medical Inc   0.68 $ 107.100  Millions$ 158.000  Millions

Date modified: 2023-11-02T13:25:01+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com